Helicobacter pylori Seropositivity and Risk of Lung Cancer

Lung cancer is the leading cause of cancer mortality worldwide. Helicobacter pylori (H. pylori) is a risk factor for distal stomach cancer, and a few small studies have suggested that H. pylori may be a potential risk factor for lung cancer. To test this hypothesis, we conducted a study of 350 lung...

Full description

Bibliographic Details
Main Authors: Koshiol, Jill, Flores, Roberto, Lam, Tram K., Taylor, Philip R., Weinstein, Stephanie J., Virtamo, Jarmo, Albanes, Demetrius, Perez-Perez, Guillermo, Caporaso, Neil E., Blaser, Martin J.
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286451/
id pubmed-3286451
recordtype oai_dc
spelling pubmed-32864512012-03-01 Helicobacter pylori Seropositivity and Risk of Lung Cancer Koshiol, Jill Flores, Roberto Lam, Tram K. Taylor, Philip R. Weinstein, Stephanie J. Virtamo, Jarmo Albanes, Demetrius Perez-Perez, Guillermo Caporaso, Neil E. Blaser, Martin J. Research Article Lung cancer is the leading cause of cancer mortality worldwide. Helicobacter pylori (H. pylori) is a risk factor for distal stomach cancer, and a few small studies have suggested that H. pylori may be a potential risk factor for lung cancer. To test this hypothesis, we conducted a study of 350 lung adenocarcinoma cases, 350 squamous cell carcinoma cases, and 700 controls nested within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) cohort of male Finnish smokers. Controls were one-to-one matched by age and date of baseline serum draw. Using enzyme-linked immunosorbent assays to detect immunoglobulin G antibodies against H. pylori whole-cell and cytotoxin-associated gene (CagA) antigens, we calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for associations between H. pylori seropositivity and lung cancer risk using conditional logistic regression. H. pylori seropositivity was detected in 79.7% of cases and 78.5% of controls. After adjusting for pack-years and cigarettes smoked per day, H. pylori seropositivity was not associated with either adenocarcinoma (OR: 1.1, 95% CI: 0.75–1.6) or squamous cell carcinoma (OR: 1.1, 95% CI: 0.77–1.7). Results were similar for CagA-negative and CagA-positive H. pylori seropositivity. Despite earlier small studies suggesting that H. pylori may contribute to lung carcinogenesis, H. pylori seropositivity does not appear to be associated with lung cancer. Public Library of Science 2012-02-24 /pmc/articles/PMC3286451/ /pubmed/22384154 http://dx.doi.org/10.1371/journal.pone.0032106 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Koshiol, Jill
Flores, Roberto
Lam, Tram K.
Taylor, Philip R.
Weinstein, Stephanie J.
Virtamo, Jarmo
Albanes, Demetrius
Perez-Perez, Guillermo
Caporaso, Neil E.
Blaser, Martin J.
spellingShingle Koshiol, Jill
Flores, Roberto
Lam, Tram K.
Taylor, Philip R.
Weinstein, Stephanie J.
Virtamo, Jarmo
Albanes, Demetrius
Perez-Perez, Guillermo
Caporaso, Neil E.
Blaser, Martin J.
Helicobacter pylori Seropositivity and Risk of Lung Cancer
author_facet Koshiol, Jill
Flores, Roberto
Lam, Tram K.
Taylor, Philip R.
Weinstein, Stephanie J.
Virtamo, Jarmo
Albanes, Demetrius
Perez-Perez, Guillermo
Caporaso, Neil E.
Blaser, Martin J.
author_sort Koshiol, Jill
title Helicobacter pylori Seropositivity and Risk of Lung Cancer
title_short Helicobacter pylori Seropositivity and Risk of Lung Cancer
title_full Helicobacter pylori Seropositivity and Risk of Lung Cancer
title_fullStr Helicobacter pylori Seropositivity and Risk of Lung Cancer
title_full_unstemmed Helicobacter pylori Seropositivity and Risk of Lung Cancer
title_sort helicobacter pylori seropositivity and risk of lung cancer
description Lung cancer is the leading cause of cancer mortality worldwide. Helicobacter pylori (H. pylori) is a risk factor for distal stomach cancer, and a few small studies have suggested that H. pylori may be a potential risk factor for lung cancer. To test this hypothesis, we conducted a study of 350 lung adenocarcinoma cases, 350 squamous cell carcinoma cases, and 700 controls nested within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) cohort of male Finnish smokers. Controls were one-to-one matched by age and date of baseline serum draw. Using enzyme-linked immunosorbent assays to detect immunoglobulin G antibodies against H. pylori whole-cell and cytotoxin-associated gene (CagA) antigens, we calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for associations between H. pylori seropositivity and lung cancer risk using conditional logistic regression. H. pylori seropositivity was detected in 79.7% of cases and 78.5% of controls. After adjusting for pack-years and cigarettes smoked per day, H. pylori seropositivity was not associated with either adenocarcinoma (OR: 1.1, 95% CI: 0.75–1.6) or squamous cell carcinoma (OR: 1.1, 95% CI: 0.77–1.7). Results were similar for CagA-negative and CagA-positive H. pylori seropositivity. Despite earlier small studies suggesting that H. pylori may contribute to lung carcinogenesis, H. pylori seropositivity does not appear to be associated with lung cancer.
publisher Public Library of Science
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286451/
_version_ 1611508235023417344